Key Record Dates
ClinicalTrials.gov Identifier: | NCT02653209 |
---|---|
Brief Title: | TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes. (TriMaster) |
First Submitted : | January 8, 2016 |
First Submitted that Met QC Criteria : | January 8, 2016 |
First Posted : | January 12, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | March 30, 2021 |
Last Update Posted : | April 1, 2021 |